4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-028424
CEO and CFO bought 4,100 shares at $12.62 ($51,742)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-12-18 | Purchase | +4,100 | $12.62 | $51,742 | 5,592,202 | D: show line 1 in the form |
| Open-market purchases · 4,100 sh · avg $12.62 · $51,742 | |||||||
Loading xslF345X05/ownership.xml…